This topic contains a solution. Click here to go to the answer

Author Question: Structured data openly shared between companies is called ____. a. big data b. open source ... (Read 49 times)

K@

  • Hero Member
  • *****
  • Posts: 608
Structured data openly shared between companies is called ____.
 a. big data
  b. open source information
  c. universal product codes
  d. scanner data

Question 2

In a particular conjoint study, the variables club, upgrade and fee are the predictors. Which model properly corresponds to this?
 a. Rating = b0 + b1 Club + b2 Upgrade + b3 Fee + error
  b. Rating = b0 + b1 Club  b2 Upgrade  b3 Fee  error
  c. Rating = (b0 + b1 Club + b2 Upgrade + b3 Fee) / error
  d. Rating = b0  b1 Club + b2 Upgrade + b3 Fee  error



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cupcake16

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

B

Answer to Question 2

a




K@

  • Member
  • Posts: 608
Reply 2 on: Jun 28, 2018
Great answer, keep it coming :)


ASDFGJLO

  • Member
  • Posts: 335
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library